Prior notification of a concentration (Case M.10905 – IRISH LIFE WELLBEING / CENTRIC HEALTH PRIMARY CARE / CAREPATH CONNECT) Candidate case for simplified procedure (Text with EEA relevance) 2022/C 446/10
Date: 2022-11-24
Institutions: Directorate-General for Competition, European Commission
Subjects: Ireland, economic concentration, health care, health insurance, investment company, life assurance, merger control, pension scheme, physician, provision of services








C_2022446EN.01003601.xml










24.11.2022   


EN


Official Journal of the European Union


C 446/36






Prior notification of a concentration
(Case M.10905 – IRISH LIFE WELLBEING / CENTRIC HEALTH PRIMARY CARE / CAREPATH CONNECT)
Candidate case for simplified procedure
(Text with EEA relevance)
(2022/C 446/10)

1.   
On 16 November 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


Irish Life Wellbeing Limited (‘ILW’, Ireland),










—


Centric Health Primary Care Limited (‘CH’, Ireland).




ILW and CH will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Carepath Connect Designated Activity Company (‘Carepath’, Ireland). ILW and CH are referred to together as ‘the Parties’.
The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.


2.   
The business activities of the undertakings concerned and the newly set-up joint venture are the following:






—


ILW is part of the Irish Life Group, which provides life assurance, pensions and wealth management, health insurance and health and wellbeing services in Ireland. It belongs to the Power Corporation of Canada group, an international management and holding company,










—


CH provides primary healthcare services (general practitioner and specialty) to patients and medical recruitment services to general practitioner practices and hospitals in Ireland. It is part of Rothschild & Co Investment Managers group, a global financial services group,










—


Carepath will design and implement treatment step plans for primary healthcare, which will aim to improve patients' experience and reduce treatment costs in Ireland.






3.   

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.



4.   

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.



5.   
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.10905 – IRISH LIFE WELLBEING / CENTRIC HEALTH PRIMARY CARE / CAREPATH CONNECT
Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Fax +32 22964301
Postal address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  OJ C 366, 14.12.2013, p. 5.